PT1107795E - Tiomolibdato associado com pelo menos um hidrato de carbono e o seu uso para evitar ou tratar doencas caracterizadas por uma vascularizacao tais como cancro degeneracao macular do tipo humido artrite reumatoide - Google Patents
Tiomolibdato associado com pelo menos um hidrato de carbono e o seu uso para evitar ou tratar doencas caracterizadas por uma vascularizacao tais como cancro degeneracao macular do tipo humido artrite reumatoideInfo
- Publication number
- PT1107795E PT1107795E PT99952903T PT99952903T PT1107795E PT 1107795 E PT1107795 E PT 1107795E PT 99952903 T PT99952903 T PT 99952903T PT 99952903 T PT99952903 T PT 99952903T PT 1107795 E PT1107795 E PT 1107795E
- Authority
- PT
- Portugal
- Prior art keywords
- cancer
- tiomolibdate
- vascularization
- avoid
- rheumatoid arthritis
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
- 201000011510 cancer Diseases 0.000 title abstract 2
- FRYDSOYOHWGSMD-UHFFFAOYSA-N [C].O Chemical compound [C].O FRYDSOYOHWGSMD-UHFFFAOYSA-N 0.000 title 1
- 208000002780 macular degeneration Diseases 0.000 title 1
- 206010039073 rheumatoid arthritis Diseases 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 1
- 238000002648 combination therapy Methods 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 239000010949 copper Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9910398P | 1998-09-04 | 1998-09-04 | |
| US10175998P | 1998-09-25 | 1998-09-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1107795E true PT1107795E (pt) | 2003-04-30 |
Family
ID=26795562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99952903T PT1107795E (pt) | 1998-09-04 | 1999-09-03 | Tiomolibdato associado com pelo menos um hidrato de carbono e o seu uso para evitar ou tratar doencas caracterizadas por uma vascularizacao tais como cancro degeneracao macular do tipo humido artrite reumatoide |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1107795B1 (pt) |
| JP (1) | JP2002524426A (pt) |
| KR (1) | KR100702279B1 (pt) |
| CN (1) | CN100548383C (pt) |
| AT (1) | ATE228375T1 (pt) |
| AU (1) | AU773848B2 (pt) |
| CA (1) | CA2341752A1 (pt) |
| DE (1) | DE69904203T2 (pt) |
| DK (1) | DK1107795T3 (pt) |
| ES (1) | ES2188261T3 (pt) |
| IL (1) | IL141550A0 (pt) |
| NZ (1) | NZ510038A (pt) |
| PT (1) | PT1107795E (pt) |
| WO (1) | WO2000013712A2 (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6703050B1 (en) | 1998-09-04 | 2004-03-09 | The Regents Of The University Of Michigan | Methods and compositions for the prevention or treatment of cancer |
| US7632803B2 (en) | 1999-10-01 | 2009-12-15 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
| US7592304B2 (en) | 1999-10-01 | 2009-09-22 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
| WO2003099223A2 (en) * | 2002-05-24 | 2003-12-04 | The Regents Of The University Of Michigan | Copper lowering treatment of inflammatory and fibrotic diseases |
| US20070292533A1 (en) * | 2002-05-24 | 2007-12-20 | Regents Of The University Of Michigan | Copper lowering treatment of autoimmune diseases |
| US7189865B2 (en) * | 2002-07-23 | 2007-03-13 | Attenuon, Llc | Thiomolybdate analogues and uses thereof |
| CA2493341A1 (en) | 2002-07-23 | 2004-01-29 | The Regents Of The University Of Michigan | Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| AU2004247059A1 (en) * | 2003-05-27 | 2004-12-23 | Attenuon L.L.C. | Thiotungstate analogues and uses thereof |
| AU2005217623A1 (en) * | 2004-02-24 | 2005-09-09 | Attenuon Llp | Inhibition of superoxide dismutase by tetrathiomolybdate: identification of new anti-angiogenic and antitumor agents |
| CA2675230A1 (en) * | 2006-01-10 | 2008-07-26 | Pipex, Inc. | Pharmaceutical compositions and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases |
| WO2009009622A2 (en) * | 2007-07-09 | 2009-01-15 | Pipex Pharmaceuticals, Inc. | Pharmaceutical compositions, including attm, and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases |
| KR100972355B1 (ko) * | 2008-05-08 | 2010-07-26 | 고려전자주식회사 | 순간식 가스보일러의 온수공급라인용 써모밸브조립체 |
| US10478455B2 (en) | 2010-03-30 | 2019-11-19 | Ucl Business Ltd | Therapeutic use of tetrathiomolybdate |
| GB201005394D0 (en) * | 2010-03-30 | 2010-05-12 | Magnus Intellectual Property Ltd | Therapy |
| US20160220500A1 (en) * | 2014-11-14 | 2016-08-04 | Kent State University | Targeting Intracellular Copper Ions for Inhibiting Angiogenesis Using Nanoparticles of Ternary Inorganic Metal Sulfide M1M2S4 (M1, independently, is Mg, Ca, Mn, Fe, or Zn; M2 = Mo or W) Compounds to Treat Metastatic Cancer |
| CN108634322A (zh) * | 2018-05-16 | 2018-10-12 | 刘华 | 一种预防和调理癌症的方法 |
| AU2019277560B2 (en) * | 2018-06-01 | 2025-04-24 | Incyte Corporation | Dosing regimen for the treatment of PI3K related disorders |
-
1999
- 1999-09-03 NZ NZ510038A patent/NZ510038A/en not_active IP Right Cessation
- 1999-09-03 AU AU64960/99A patent/AU773848B2/en not_active Ceased
- 1999-09-03 IL IL14155099A patent/IL141550A0/xx unknown
- 1999-09-03 CA CA002341752A patent/CA2341752A1/en not_active Abandoned
- 1999-09-03 EP EP99952903A patent/EP1107795B1/en not_active Expired - Lifetime
- 1999-09-03 ES ES99952903T patent/ES2188261T3/es not_active Expired - Lifetime
- 1999-09-03 KR KR1020017002840A patent/KR100702279B1/ko not_active Expired - Fee Related
- 1999-09-03 CN CNB998117331A patent/CN100548383C/zh not_active Expired - Fee Related
- 1999-09-03 DK DK99952903T patent/DK1107795T3/da active
- 1999-09-03 DE DE69904203T patent/DE69904203T2/de not_active Expired - Lifetime
- 1999-09-03 WO PCT/US1999/020374 patent/WO2000013712A2/en not_active Ceased
- 1999-09-03 AT AT99952903T patent/ATE228375T1/de not_active IP Right Cessation
- 1999-09-03 JP JP2000568518A patent/JP2002524426A/ja active Pending
- 1999-09-03 PT PT99952903T patent/PT1107795E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ510038A (en) | 2003-10-31 |
| EP1107795B1 (en) | 2002-11-27 |
| DK1107795T3 (da) | 2003-03-24 |
| WO2000013712A3 (en) | 2000-09-28 |
| CA2341752A1 (en) | 2000-03-16 |
| KR20010082190A (ko) | 2001-08-29 |
| AU773848B2 (en) | 2004-06-10 |
| ATE228375T1 (de) | 2002-12-15 |
| DE69904203D1 (de) | 2003-01-09 |
| JP2002524426A (ja) | 2002-08-06 |
| AU6496099A (en) | 2000-03-27 |
| DE69904203T2 (de) | 2003-08-14 |
| CN100548383C (zh) | 2009-10-14 |
| CN1457261A (zh) | 2003-11-19 |
| IL141550A0 (en) | 2002-03-10 |
| EP1107795A2 (en) | 2001-06-20 |
| KR100702279B1 (ko) | 2007-04-02 |
| WO2000013712A2 (en) | 2000-03-16 |
| ES2188261T3 (es) | 2003-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1107795E (pt) | Tiomolibdato associado com pelo menos um hidrato de carbono e o seu uso para evitar ou tratar doencas caracterizadas por uma vascularizacao tais como cancro degeneracao macular do tipo humido artrite reumatoide | |
| IL267381A (en) | A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders | |
| BRPI0409919A (pt) | combinações para o tratamento de doenças envolvendo proliferação, migração ou apoptose celular de células de células de mieloma, ou angiogênese | |
| DE60216139D1 (de) | Arylharnstoff-verbindungen in kombination mit anderen zytostatisch oder zytotoxisch wirksamen stoffen zur behandlungen menschlicher krebserkrankungen | |
| SI1771474T1 (sl) | Inhibitorji angiopoetinu podobnega proteina kombinacije in njihova uporaba | |
| MX2007004551A (es) | Compuestos tiadiazol y metodos de uso. | |
| MX2020008680A (es) | Terapia de combinacion con apilimod y agentes glutamatergicos. | |
| BR0108715A (pt) | Compostos de 3,4-diidro-1h-pirimido[4,5-d]-pirimidin-2-ona 1,5-dissubstituìdos e seu uso no tratamento de doenças mediadas pela cinase csbp/p38 | |
| BR0206046A (pt) | Usos de uma combinação e de sapogenina protopanaxadiol ou sapogenina protopanaxatriol, e, composição farmacêutica | |
| EA200600921A1 (ru) | Способы и композиции с применением талидомида для лечения и менеджмента рака и других заболеваний | |
| BRPI0409926A (pt) | saposina c-dops: um agente antitumor | |
| TW200640944A (en) | VGF polypeptides and methods of treating VGF-related disorders | |
| BRPI0518567A2 (pt) | composiÇço farmacÊutica, usos de uma composiÇço farmacÊutica, de sabcomelina ou um sal farmaceuticamente aceitÁvel da mesma, de pelo menos um agente neurolÉptico e de uma combinaÇço de sabcomelina ou um sal farmaceuticamente aceitÁvel da mesma e pelo menos um agente neurolÉptico, kit de partes para uso no tratamento de um dustérbio psicàtico, mÉtodo de tratamento de um distérbio psicàtico, e, sabcomelina ou um sal farmaceuticamente aceitÁvel da mesma | |
| TW200727903A (en) | Stable pharmaceutical compositions of 5, 10 methylenetetrahydrofolate | |
| EP0281070A3 (en) | Pharmaceutical composition for the treatment of cancer | |
| MXPA02000680A (es) | Polipeptidos vgf y metodos para tratar desordenes relacionados con vgf. | |
| MXPA00010254A (es) | Tratamiento de disfuncion sexual en ciertos grupos de pacientes. | |
| EP1234585A3 (en) | Methods and compositions for the prevention or treatment of cancer | |
| DE602004019135D1 (de) | Screeningverfahren für Kombinationen von biologischen Verbindungen | |
| PT1103270E (pt) | Tratamento de doencas auto-imunes em mamiferos |